Expand VRTX Menu
VRTX MENU

VRTX Latest Press Releases

-- January 11, 2026 --

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Business Wire 5:00 PM

-- December 16, 2025 --

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes Globe Newswire 12:00 PM

-- December 6, 2025 --

Vertex Presents New Data on CASGEVY, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions Business Wire 7:01 AM

-- November 19, 2025 --

Vertex to Participate in the Citi's 2025 Global Healthcare Conference on December 3 Business Wire 4:00 PM

-- November 8, 2025 --

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week Business Wire 5:15 PM

-- November 3, 2025 --

Vertex Reports Third Quarter 2025 Financial Results Business Wire 4:02 PM

-- October 27, 2025 --

Vertex to Participate in the UBS Global Healthcare Conference on November 11 Business Wire 4:00 PM

-- October 23, 2025 --

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK at the North American Cystic Fibrosis Conference Business Wire 9:00 AM

-- October 17, 2025 --

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week Business Wire 9:04 AM

-- October 6, 2025 --

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd Business Wire 4:00 PM

-- September 25, 2025 --

Vertex Announces Key Advancements Across Kidney Portfolio Business Wire 7:45 AM

-- September 23, 2025 --

Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain Business Wire 9:00 AM

-- September 18, 2025 --

Vertex Announces CASGEVY Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy Business Wire 8:30 AM

-- September 11, 2025 --

Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis Business Wire 9:05 AM

-- September 2, 2025 --

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases Business Wire 9:00 AM

-- August 20, 2025 --

Vertex to Participate in Upcoming September Investor Conferences Business Wire 4:00 PM
Market Data Delayed 15 Minutes